UCSF

ZINC13581975

Substance Information

In ZINC since Heavy atoms Benign functionality
June 22nd, 2008 22 No

Download: MOL2 SDF SMILES Flexibase

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 3.23 6.35 -10.73 2 4 0 65 304.378 2
Lo Low (pH 4.5-6) 3.23 6.63 -32.14 3 4 1 66 305.386 2
Lo Low (pH 4.5-6) 3.23 6.61 -38.83 3 4 1 66 305.386 2
Lo Low (pH 4.5-6) 3.23 6.89 -81.1 4 4 2 67 306.394 2
Lo Low (pH 4.5-6) 3.23 6.64 -36.72 3 4 1 66 305.386 2
Lo Low (pH 4.5-6) 3.23 6.91 -87.48 4 4 2 67 306.394 2
Lo Low (pH 4.5-6) 3.23 6.9 -93.7 4 4 2 67 306.394 2
Lo Low (pH 4.5-6) 3.23 7.17 -165.99 5 4 3 68 307.402 2

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
TGFR1-1-E TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic Eukaryotes 3981 0.34 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
TGFR1_HUMAN P36897 TGF-beta Receptor Type I, Human 3980 0.34 Binding ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Downregulation of TGF-beta receptor signaling
SMAD2/3 MH2 Domain Mutants in Cancer
SMAD2/3 Phosphorylation Motif Mutants in Cancer
TGF-beta receptor signaling activates SMADs
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
TGFBR1 KD Mutants in Cancer
TGFBR1 LBD Mutants in Cancer
TGFBR2 Kinase Domain Mutants in Cancer

Analogs ( Draw Identity 99% 90% 80% 70% )